Format

Send to

Choose Destination
Virology. 2012 Nov 25;433(2):346-55. doi: 10.1016/j.virol.2012.08.029. Epub 2012 Sep 11.

Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle.

Author information

1
Molecular Biology Interdepartmental Ph.D. Program, Molecular Biology Institute, David Geffen School of Medicine at University of California, Los Angeles, California, CA, United States. RnKhch@ucla.edu

Abstract

We have previously demonstrated that quercetin, a bioflavonoid, blocks hepatitis C virus (HCV) proliferation by inhibiting NS5A-driven internal ribosomal entry site (IRES)-mediated translation of the viral genome. Here, we investigate the mechanisms of antiviral activity of quercetin and six additional bioflavonoids. We demonstrate that catechin, naringenin, and quercetin possess significant antiviral activity, with no associated cytotoxicity. Infectious virion secretion was not significantly altered by these bioflavonoids. Catechin and naringenin demonstrated stronger inhibition of infectious virion assembly compared to quercetin. Quercetin markedly blocked viral translation whereas catechin and naringenin demonstrated mild activity. Similarly quercetin completely blocked NS5A-augmented IRES-mediated translation in an IRES reporter assay, whereas catechin and naringenin had only a mild effect. Moreover, quercetin differentially inhibited HSP70 induction compared to catechin and naringenin. Thus, the antiviral activity of these bioflavonoids is mediated through different mechanisms. Therefore combination of these bioflavonoids may act synergistically against HCV.

PMID:
22975673
PMCID:
PMC3478964
DOI:
10.1016/j.virol.2012.08.029
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center